P1.15-02. Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors
Back to course
Pdf Summary
Asset Subtitle
Claudia Proto, Italy
Meta Tag
Speaker Claudia Proto, Italy
Topic Metastatic Non-small Cell Lung Cancer – Immunotherapy
circulating microRNA
clinical outcomes
non-small cell lung cancer
immune checkpoint inhibitors
prediction of survival
treatment response
microRNA ratios
progression-free survival
microRNA expression
personalize therapy
Powered By